BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23974666)

  • 1. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients.
    Palmedo H; Marx C; Ebert A; Kreft B; Ko Y; Türler A; Vorreuther R; Göhring U; Schild HH; Gerhardt T; Pöge U; Ezziddin S; Biersack HJ; Ahmadzadehfar H
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):59-67. PubMed ID: 23974666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
    Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
    Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions.
    Teyateeti A; Tocharoenchai C; Muangsomboon K; Komoltri C; Pusuwan P
    J Med Assoc Thai; 2017 Jan; 100(1):100-10. PubMed ID: 29911774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases.
    Zhang Y; Li B; Wu B; Yu H; Song J; Xiu Y; Shi H
    Ann Nucl Med; 2020 Aug; 34(8):549-558. PubMed ID: 32583153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
    Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
    Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients.
    Mavriopoulou E; Zampakis P; Smpiliri E; Spyridonidis T; Rapti E; Haberkorn U; Makatsoris T; Apostolopoulos DJ
    Hell J Nucl Med; 2018; 21(2):125-133. PubMed ID: 30089314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?
    Ndlovu X; George R; Ellmann A; Warwick J
    Nucl Med Commun; 2010 Jul; 31(7):659-65. PubMed ID: 20395878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
    Zhang Y; Shi H; Li B; Cai L; Gu Y; Xiu Y
    Nuklearmedizin; 2015; 54(6):255-61. PubMed ID: 26615876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hybrid
    Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
    Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate characterization of
    Zhang L; He Q; Zhou T; Zhang B; Li W; Peng H; Zhong X; Ma L; Zhang R
    BMC Med Imaging; 2019 May; 19(1):44. PubMed ID: 31146746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of whole-body SPECT/CT in bone metastasis detection using
    Alqahtani MM; Fulton R; Constable C; Willowson KP; Kench PL
    Clin Radiol; 2020 Dec; 75(12):961.e11-961.e24. PubMed ID: 32868091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
    Oh JR; Byun BH; Hong SP; Chong A; Kim J; Yoo SW; Kang SR; Kim DY; Song HC; Bom HS; Min JJ
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1459-68. PubMed ID: 21505897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
    Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
    BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.